New study aims to spot hidden cancer spread in Hard-to-Detect breast cancer type
NCT ID NCT07635654
First seen Jun 11, 2026 · Last updated Jun 11, 2026
Summary
This study looks at whether a special type of MRI (WB-DWI/MRI) and blood tests for tumor DNA can better detect cancer spread in people with metastatic invasive lobular breast cancer, a type that is often missed by standard scans. About 43 participants starting their first treatment will get both standard scans and the new MRI, plus blood tests, over up to 30 months. The goal is to see if these tools help doctors make more accurate treatment decisions and improve patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC INVASIVE LOBULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.